Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2023-11-01
2051-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy
NCT03907397
Canadian Peanut Thresholds Study
NCT01812798
Intranasal Diagnostics in Food Allergy: a Feasibility Study
NCT02159833
Food Allergy Registry at a Single Site
NCT03539705
Relevance of Sensitization to Legumes in Children Allergic to Peanut
NCT04329078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients with suspected or confirmed food allergy
Oral food challenge
Patients will undergo oral food challenge with increasing amounts of food allergen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral food challenge
Patients will undergo oral food challenge with increasing amounts of food allergen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ability to discontinue all antihistamines for 1 week before oral food challenge.
Exclusion Criteria
2. Allergies to any component of the oral challenge vehicle
3. Unstable conditions including uncontrolled asthma or chronic urticaria
4. Any clinically significant disease/chronic medical condition which may interfere with study evaluations.
3 Months
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AAAAI Foundation
UNKNOWN
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Hamilton Health Sciences Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Derek Chu, MD PhD FRCPC
Role: PRINCIPAL_INVESTIGATOR
Hamilton Health Sciences & McMaster University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McMaster University Medical Centre
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Heather Le
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIF-20500
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.